Why the study?
Does emerging norovirus GII.P16-GII.2 have a higher viral load compared to pandemic GII.Pe-GII.4 and epidemic GII.P17-GII.17 in hospitalized patients with norovirus gastroenteritis?
Observational (n=1,465)
No
Does emerging norovirus GII.P16-GII.2 have a higher viral load compared to pandemic GII.Pe-GII.4 and epidemic GII.P17-GII.17 in hospitalized patients with norovirus gastroenteritis?
The emerging recombinant norovirus GII.P16-GII.2 exhibits higher viral loads across age groups compared to other genotypes, potentially explaining its high transmissibility and widespread circulation.
Answers are grounded in this paper and cite their sources.
May indicate greater transmissibility of GII.P16-GII.2 in older adults; hypothesis-generating for genotype-specific surveillance and prospective validation.
We compared viral load of emerging recombinant norovirus GII.P16-GII.2 with those for pandemic GII.Pe-GII.4 and epidemic GII.P17-GII.17 genotypes among inpatients in Hong Kong. Viral load of GII.P16-GII.2 was higher than those for other genotypes in different age groups. GII.P16-GII.2 is as replication competent as the pandemic genotype, explaining its high transmissibility and widespread circulation.
No takes yet. Share an insight, caveat, or question.
Cheung et al. (2018) conducted an observational in Norovirus gastroenteritis (n=1,465). Norovirus genotype GII.P16-GII.2 vs. Pandemic GII.Pe-GII.4 and epidemic GII.P17-GII.17 genotypes was evaluated on Fecal viral load (median Ct value) in children <5 years (p=0.200).
Synapse has enriched 10 related papers. Consider them for comparative context: